NCT05039229

Brief Summary

Workers in the salmon industry are at risk of developing allergies and respiratory diseases, including asthma, due to occupational exposure to bioaerosols, i.e. biological agents such as allergens, enzymes and endotoxins, in their work environment. The overall objective of this intervention trial is to identify effective and feasible control measures (interventions) that reduce exposure to these bioaerosols. The project comprises nine salmon processing factories in northern, central and western Norway. The factories are allocated to either one of the two intervention arms or the control group. In all factories, an assessment of exposure to bioaerosols will be performed. In addition, employees will be invited to undergo a health examination and fill out a self-administered questionnaire including information on demographics, work tasks, health and health promoting factors. The intervention trial is part of a broader study that comprises several substudies including the identification of clinically relevant allergens, investigation of exposure-response relationship between the exposure to individual bioactive agents in bioaerosols and investigations of prevalence of airway symptoms, altered lung function, skin symptoms or immunological responses indicating hypersensitivity. Finally the project includes the identification of health promoting factors that are present in the salmon processing industry. The project is an interdisciplinary multi-center study that places great emphasis on a close dialogue between the researchers and industry in all phases of the project.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 6, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 9, 2021

Completed
11 days until next milestone

Study Start

First participant enrolled

September 20, 2021

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
Last Updated

December 17, 2024

Status Verified

December 1, 2024

Enrollment Period

1.8 years

First QC Date

September 6, 2021

Last Update Submit

December 11, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change of salmon processing workers' personal exposure to inhalable protein

    Change in inhalable total protein (ug/m3) in the workers' breathing zone from pre-intervention (baseline, T1) to post-intervention (follow-up, T2). Differences in mean concentration of full shift measurements (8 hours) between intervention groups and between intervention groups and control group will be analyzed.

    Measurements at T1 compared to T2, 12 months after T1.

Secondary Outcomes (13)

  • Change of salmon processing workers' personal exposure to proteases

    Measurements at T1 compared to T2, 12 months after T1.

  • Change in area concentration of airborne total protein (stationary measurements)

    Measurements at T1 compared to T2, 12 months after T1.

  • Change of salmon processing workers' personal exposure to airborne fish allergens

    Measurements at T1 compared to T2, 12 months after T1.

  • Change of salmon processing workers' personal exposure to airborne endotoxins

    Measurements at T1 compared to T2, 12 months after T1.

  • Change in salmon processing workers' self-reported symptoms from the upper airways

    Data collected at T1 compared to T2, 12 months after T1.

  • +8 more secondary outcomes

Study Arms (3)

Nozzles (NZ)

EXPERIMENTAL

Intervention with the aim of reducing bioaerosol exposure for the employees, targeting alteration of nozzles or nozzle function along the production line.

Other: Nozzles (NZ)

Cleaning of surfaces (CS)

EXPERIMENTAL

Intervention with the aim of reducing bioaerosol exposure for the employees while cleaning their personal operating areas (work benches and part of production lines) during work operations or while cleaning floor areas.

Other: Cleaning of surfaces (CS)

Control (CTR)

NO INTERVENTION

Work is to be carried out as usual without any intervention measures. Follow-up according to the same schedule as for the other intervention groups.

Interventions

Technical intervention targeting alteration of nozzles or nozzle function along the production line, e.g. by manipulation of nozzle dimensions, alteration of operating pressure or shielding of the nozzle's output stream. How the intervention is to be carried out in detail in the respective factory is to be developed in collaboration with the factory staff. This can include local specific characteristics, specific location of intervention or others.

Nozzles (NZ)

Behavioural or technical intervention. This can include increased use of swabbing instead of flushing with water hoses or alterations in use of water hoses for cleaning. Examples for the latter are a reduced flushing frequency, reduction of number of employees executing the work, alterations of hose dimension or nozzles on hoses. How the intervention is to be carried out in detail in the respective factory is to be developed in collaboration with the factory staff. This can include local specific characteristics, specific location of intervention or others.

Cleaning of surfaces (CS)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Exposure assessment study
  • Monday and Thursday (n=12 workers): Slaughtering department (n=5), filleting department (n=4) and other (n=3).
  • Tuesday and Wednesday (n=12 workers): Slaughtering department (n=3), filleting department (n=3), packing department (n=2), laboratory/technical department (n=2) and central control room/administration (n=2).
  • For spirometry measurements: heart attack, operation on eyes, stomach or in the chest region in the course of the last three months, ongoing treatment for tuberculosis or other respiratory infection, pregnancy
  • For skin prick tests: pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Nothern Norway

Tromsø, Norway

Location

Related Publications (1)

  • Hoper AC, Kirkeleit J, Thomassen MR, Irgens-Hansen K, Hollund BE, Fagernaes CF, Svedahl SR, Eriksen TE, Grgic M, Bang BE. Effects of Interventions to Prevent Work-Related Asthma, Allergy, and Other Hypersensitivity Reactions in Norwegian Salmon Industry Workers (SHInE): Protocol for a Pragmatic Allocated Intervention Trial and Related Substudies. JMIR Res Protoc. 2023 Jul 19;12:e48790. doi: 10.2196/48790.

    PMID: 37467018BACKGROUND

MeSH Terms

Conditions

Asthma, OccupationalHypersensitivity

Condition Hierarchy (Ancestors)

AsthmaBronchial DiseasesRespiratory Tract DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateImmune System DiseasesOccupational Diseases

Study Officials

  • Berit E Bang, PhD

    University Hospital of North Norway

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 6, 2021

First Posted

September 9, 2021

Study Start

September 20, 2021

Primary Completion

June 30, 2023

Study Completion

April 30, 2025

Last Updated

December 17, 2024

Record last verified: 2024-12

Locations